Month: May 2021

The net asset value (NAV) of EfTEN Real Estate Fund III AS as of 30.04.2021 was 16.83 euros. The net asset value of the EPRA share (net book value excluding deferred income tax liability and fair value of interest rate derivatives) as of 30.04.2021 was 17.96 euros. NAV decreased by 3.0% in April due to the announcement of dividends. Without the dividends announcement, the fund’s NAV and EPRA NAV would have increased by 1% in April. In April, the consolidated sales revenue of EfTEN Real Estate Fund III AS was 951 thousand euros, which is 9 thousand euros less than in March. Sales revenue decreased mainly due to Estonia’s restrictions to shops and shopping centers and on temporary rental discounts granted to Hortes horticultural centers for one month in April in the total amount of 27 thousand euros. The impact of Hortes discounts...

ROTTERDAM, The Netherlands (11 May 2021) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today published the convocation and agenda for its Annual General Meeting of shareholders (“AGM”), which will be held on Tuesday 22 June 2021 at 10:30 CET in Rotterdam, The Netherlands. The convocation, agenda, and further documentation for the AGM are available in the Investors’ section of IMCD’s website. In view of the continuing COVID-19 pandemic, precautionary measures apply to limit exposure for IMCD’s employees, shareholders, and other stakeholders. IMCD encourages shareholders to exercise their online proxy voting rights in advance of the meeting, instead of attending the meeting in person. There will be no social gathering surrounding the AGM and depending on the circumstances at the time, the...

Data from the first positive phase III study of a cancer immunotherapy in early, resected lung cancer Studies in personalised healthcare exploring tumour agnostic treatments that demonstrate the impact of coupling biomarker testing with targeted therapies to develop individualised treatment plans New data, and drug combination strategies for the treatment of lymphoma from the largest haematology portfolio in industryBasel, 11 May 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 19 approved and investigational medicines across 20 cancer types will be presented at the 2021 ASCO Annual Meeting, which will be held 4-8 June, 2021. A total of 132 abstracts that include a Roche medicine will be presented at this year’s meeting. These data advance oncology by showing the importance...

Please find the first quarter report for Sbanken Boligkreditt AS enclosed. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentSbanken Boligkreditt AS – Q1 2021 Report

Bergen, 11 May 2021. The Sbanken group generated a profit before tax of NOK 242.9 million in the first quarter of 2021, compared to NOK 239.0 million in the first quarter of 2020. Net interest income decreased by 45.9 million, while net fee and commission income increased by 0.2 million. Return on equity (ROE) in the first quarter was 10.7 per cent. Adjusting for excess CET1 capital above the 13.0 per cent target, ROE for the quarter equalled 14.3 pent. At quarter-end, customer lending totalled NOK 83.2 billion, corresponding to an annual lending growth rate of 0.2 per cent. Mortgage lending was flat from the previous quarter. Funds under management (FuM) increased to NOK 25.9 billion, corresponding to 86 per cent growth year-on-year, supported by continued high inflow from customers. Highlights:· DNB launches recommended voluntary offer...

Trondheim, 11 May 2021: NORBIT today reported revenues for the first quarter of 2021 of NOK 148.7 million, compared with NOK 151.6 million in the same quarter previous year. The company achieved an EBITDA for the quarter of NOK 17.7 million, representing a 12 per cent margin. Oceans grew by 32 per cent in a seasonally slow quarter and revenues came in at NOK 68.5 million with an EBITDA margin of 31 per cent. PIR increased its revenues by 7 per cent to NOK 67.2 million, driven by higher sales of contract manufacturing and R&D services, and reported improved profitability. “We are satisfied with the strong growth in both Oceans and PIR during the quarter. The demand for sonar systems is solid with Oceans delivering multiple WINGHEAD sonars to a leading global survey company. PIR experienced higher activity in contract manufacturing...

In the first quarter of 2021, Hexagon Purus Group generated NOK 57 (48) million in revenue and recorded operating profit before depreciation (EBITDA) of NOK -62 (-43) million. Revenue growth was driven by increased activity in hydrogen distribution applications as well as aerospace with slightly lower revenue contribution from heavy duty vehicle applications due to the completion of a battery electric (BEV) truck demonstration program in Q1 2020. Continued investments in personnel and infrastructure to support and accelerate Hexagon Purus’ future growth drive negative profitability. Key developmentsSigned joint venture agreements with CIMC Enric in March 2021 to enter China which is expected to be the world’s largest zero emission hydrogen vehicle and distribution market Signed a multi-year agreement (as part of a broader agreement together...

In the first quarter of 2021, Hexagon Purus Group generated NOK 57 (48) million in revenue and recorded operating profit before depreciation (EBITDA) of NOK -62 (-43) million. Revenue growth was driven by increased activity in hydrogen distribution applications as well as aerospace with slightly lower revenue contribution from heavy duty vehicle applications due to the completion of a battery electric (BEV) truck demonstration program in Q1 2020. Continued investments in personnel and infrastructure to support and accelerate Hexagon Purus’ future growth drive negative profitability. Key developmentsSigned joint venture agreements with CIMC Enric in March 2021 to enter China which is expected to be the world’s largest zero emission hydrogen vehicle and distribution market Signed a multi-year agreement (as part of a broader agreement together...

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 May 2021 – 7.00 am CET Fagron announces voting results AGM and EGM Fagron has held the Annual General Meeting (AGM) and Extraordinary General Meeting (EGM) on Monday 10 May 2021. The AGM approved, amongst other things, the 2020 financial statements, as well as the gross dividend of € 0.18 per share. The shareholders discharged the members of board of directors and the statutory auditor. Agenda item 10 of the AGM with regard to the change of control clause of the 2020 subscription rights plan was voted down. The EGM adopted, amongst other things, the amendment of the articles of association in accordance with the Belgian Companies and Associations Code and authorized the board of directors to execute the resolutions which were approved. Agenda item 3 with regard to...

Saint-Herblain (France), May 11, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced the closing which occurred on May 10, 2021 of its previously announced global offering to specified categories of investors of an aggregate of 8,145,176 new ordinary shares, after full exercise of the overallotment option granted to the underwriters (the “Option”), consisting of a public offering of 2,850,088 American Depositary Shares (“ADSs”), each representing two ordinary shares, in the United States at an offering price of $26.41 per ADS (the “U.S. Offering”), and a concurrent private placement of 2,445,000 ordinary shares in Europe (including in France) and other countries outside of the United States...